Paper39286181
Therapeutic effect of fenugreek supplementation on type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials.
Vajdi M and 7 others. Heliyon, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Therapeutic effect of fenugreek supplementation on type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials. Papers, record 39286181. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39286181
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Therapeutic effect of fenugreek supplementation on type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21208779 | GRADE guidelines: 3. Rating the quality of evidence. | J Clin Epidemiol | 2011 | https://conductscience.org/library/papers/21208779 | PubMed |
| 2 | 19622511 | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. | Ann Intern Med | 2009 | https://conductscience.org/library/papers/19622511 | PubMed |
| 3 | 8457534 | The effect of an ethanol extract derived from fenugreek (Trigonella foenum-graecum) on bile acid absorption and cholesterol levels in rats. | Br J Nutr | 1993 | https://conductscience.org/library/papers/8457534 | PubMed |
| 4 | 9175175 | Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. | Prostaglandins Leukot Essent Fatty Acids | 1997 | https://conductscience.org/library/papers/9175175 | PubMed |
| 5 | 32385866 | Effect of fenugreek consumption on serum lipid profile: A systematic review and meta-analysis. | Phytother Res | 2020 | https://conductscience.org/library/papers/32385866 | PubMed |
| 6 | 20540147 | Diosgenin present in fenugreek improves glucose metabolism by promoting adipocyte differentiation and inhibiting inflammation in adipose tissues. | Mol Nutr Food Res | 2010 | https://conductscience.org/library/papers/20540147 | PubMed |
| 7 | 34879977 | IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. | Diabetes Res Clin Pract | 2022 | https://conductscience.org/library/papers/34879977 | PubMed |
| 8 | 32550211 | Chromium Supplementation; Negotiation with Diabetes Mellitus, Hyperlipidemia and Depression. | J Diabetes Metab Disord | 2020 | https://conductscience.org/library/papers/32550211 | PubMed |
| 9 | 36992660 | Effect of saffron and fenugreek on lowering blood glucose: A systematic review with meta-analysis. | Phytother Res | 2023 | https://conductscience.org/library/papers/36992660 | PubMed |
| 10 | 16807131 | Random-effects model for meta-analysis of clinical trials: an update. | Contemp Clin Trials | 2007 | https://conductscience.org/library/papers/16807131 | PubMed |
| 11 | 36470549 | Effects of fenugreek supplementation on the components of metabolic syndrome: A systematic review and dose-response meta-analysis of randomized clinical trials. | Pharmacol Res | 2023 | https://conductscience.org/library/papers/36470549 | PubMed |
| 12 | 18219452 | Clinical observation on trigonella foenum-graecum L. total saponins in combination with sulfonylureas in the treatment of type 2 diabetes mellitus. | Chin J Integr Med | 2008 | https://conductscience.org/library/papers/18219452 | PubMed |
| 13 | 32147060 | The effect of fenugreek seed supplementation on serum irisin levels, blood pressure, and liver and kidney function in patients with type 2 diabetes mellitus: A parallel randomized clinical trial. | Complement Ther Med | 2020 | https://conductscience.org/library/papers/32147060 | PubMed |
| 14 | 21617109 | Globalization of diabetes: the role of diet, lifestyle, and genes. | Diabetes Care | 2011 | https://conductscience.org/library/papers/21617109 | PubMed |
| 15 | 37459747 | A Placebo-Controlled, Double-Blind Clinical Investigation to Evaluate the Efficacy of a Patented Trigonella foenum-graecum Seed Extract "Fenfuro®" in Type 2 Diabetics. | J Am Nutr Assoc | 2024 | https://conductscience.org/library/papers/37459747 | PubMed |
| 16 | 15840177 | Estimating the mean and variance from the median, range, and the size of a sample. | BMC Med Res Methodol | 2005 | https://conductscience.org/library/papers/15840177 | PubMed |
| 17 | 25922446 | A Review on Ethnobotanical and Therapeutic Uses of Fenugreek (Trigonella foenum-graceum L). | J Evid Based Complementary Altern Med | 2016 | https://conductscience.org/library/papers/25922446 | PubMed |
| 18 | 32087319 | Effect of fenugreek supplementation on blood lipids and body weight: A systematic review and meta-analysis of randomized controlled trials. | J Ethnopharmacol | 2020 | https://conductscience.org/library/papers/32087319 | PubMed |
| 19 | 34181914 | Treatment of type 2 diabetes: challenges, hopes, and anticipated successes. | Lancet Diabetes Endocrinol | 2021 | https://conductscience.org/library/papers/34181914 | PubMed |
| 20 | 9310563 | Bias in meta-analysis detected by a simple, graphical test. | BMJ | 1997 | https://conductscience.org/library/papers/9310563 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942889 | Natural Products in Diabetes Mellitus: A Narrative Review of Mechanistic Insights into Metabolic Regulation and Therapeutic Potential. | Nutrients | 2026 | https://conductscience.org/library/papers/42942889 | PubMed |
| 42618886 | Combined Supplementation With Trigonella foenum-graecum and Nigella sativa Seed Powders Improves Glycemic Control, Dyslipidemia, and Organ Function in Alloxan-Induced Diabetic Rats. | J Food Sci | 2026 | https://conductscience.org/library/papers/42618886 | PubMed |
| 40006091 | Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40006091 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39286181
GET https://conductscience.org/api/papers/v1/39286181/references?page=2